Staphylococcus Aureus Skin and Soft Tissue Infections
NCT01385514 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1050
Last updated 2012-03-23
Summary
The purpose of this study is to evaluate strategies to prevent Staphylococcus aureus skin and soft tissue infections in soldiers during infantry training.
This study will be conducted on three different bases among groups of male recruits to IDF training base. They will provide nasal swabs to detect Staphylococcus aureus carriage in two time points: 1. before mixing and training in confined settings, reflecting carriage acquired before entering 2. After 14-30 days. All soldiers will be under surveillance for skin infection until the end of the training program.
Conditions
- Staphylococcus Aureus
Sponsors & Collaborators
-
Medical Corps, Israel Defense Force
lead OTHER
Principal Investigators
-
Michael Hartal, MD · International Diabetes Federation
Eligibility
- Min Age
- 18 Years
- Max Age
- 25 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-07-31
- Completion
- 2013-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Staphylococcus Aureus Caught in Action at the Site of Infection
NCT04781569 ·Status: COMPLETED
-
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
NCT00773864 ·Status: UNKNOWN
-
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
NCT06594250 ·Status: RECRUITING
-
Staphylococcus Aureus Nasal Carriage
NCT02796690 ·Status: COMPLETED
-
MRSA in a Trauma Population: Does Decolonization Prevent Infection?
NCT01820455 ·Status: COMPLETED ·Phase: NA
-
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery
NCT02595112 ·Status: COMPLETED ·Phase: NA
-
Nasal Carrying by Staphylococcus Aureus ST398 Strains in Community and Hospital Settings
NCT03869255 ·Status: UNKNOWN
-
S. Aureus Screening and Decolonization
NCT02182115 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults
NCT01018641 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
NCT01671358 ·Status: COMPLETED
-
Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
NCT02690415 ·Status: COMPLETED
-
Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus
NCT00406549 ·Status: COMPLETED
-
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
NCT02284555 ·Status: COMPLETED ·Phase: PHASE4
-
PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study
NCT03064620 ·Status: UNKNOWN
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442 ·Status: COMPLETED
-
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment
NCT00997139 ·Status: COMPLETED ·Phase: NA
-
Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure
NCT03685487 ·Status: COMPLETED
-
Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)
NCT01589185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1
-
Staphylococcus Aureus Bacteraemia (SAB)-Support-Study
NCT06249451 ·Status: COMPLETED ·Phase: NA
-
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
NCT02282605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
NCT02357966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED